文献速递乳腺乳腺X线MR

对比增强乳腺X线摄影、简化乳腺MRI与标准乳腺MRI在乳腺癌筛查中的性能比较

Comparative Performance of Contrast-enhanced Mammography, Abbreviated Breast MRI, and Standard Breast MRI for Breast Cancer Screening.
PubMed 文献 · Radiology · 2023-01-01

单机构前瞻性盲法阅片研究纳入246名转诊乳腺MRI的女性,比较CEM、ABMRI与标准MRI的诊断性能。ABMRI与标准MRI性能相当;CEM召回率和假阳性活检推荐率更低、特异度更高,但癌症检出率和敏感度显著低于标准MRI。

要点

  • ABMRI由标准MRI生成,其性能与标准MRI无差异,可能支持更高效的MRI筛查。
  • CEM较标准MRI召回率更低(14.0% vs 22.8%)、特异度更高(87.8% vs 80.2%)。
  • CEM癌症检出率(22.4 vs 36.6/1000)和敏感度(61.1% vs 100%)显著低于标准MRI。

核心结论

  • ABMRI性能与标准MRI相当,可能支持更高效的MRI筛查;CEM召回率更低、特异度更高,但以癌症检出率和敏感度低于标准MRI为代价,这些权衡需在广泛筛查前进一步考虑患者人群特征。

研究设计与样本

  • 单机构前瞻性盲法阅片研究,2018年1月至2021年6月纳入转诊乳腺MRI的女性,共246名参与者(中位年龄51岁,IQR 43-61岁),获得492对CEM与ABMRI判读。

诊断标准与关键数值

  • 49次MRI扫描中病灶被推荐活检,其中9个病灶病理为恶性;CEM vs 标准MRI:召回率14.0% vs 22.8%(差值-8.7%,95%CI -14.0至-3.5),每1000次检查假阳性活检推荐率65.0 vs 162.6(差值-97.6,95%CI -146.3至-50.8),特异度87.8% vs 80.2%(差值7.6%,95%CI 2.3至13.1),癌症检出率22.4 vs 36.6(差值-14.2,95%CI -28.5至-2.0),敏感度61.1% vs 100%(差值-38.9%,95%CI -66.7至-12.5)。

临床应用与阅片要点

  • ABMRI与标准MRI性能无差异;CEM较标准MRI和ABMRI召回率更低、特异度更高,但癌症检出率和敏感度低于标准MRI,作者认为这些权衡在广泛筛查前需进一步考虑患者人群特征。

局限性

  • 原文自述这些权衡需在广泛筛查CEM前进一步考虑患者人群特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Contrast-enhanced mammography (CEM) and abbreviated breast MRI (ABMRI) are emerging alternatives to standard MRI for supplemental breast cancer screening. Purpose To compare the diagnostic performance of CEM, ABMRI, and standard MRI. Materials and Methods This single-institution, prospective, blinded reader study included female participants referred for breast MRI from January 2018 to June 2021. CEM was performed within 14 days of standard MRI; ABMRI was produced from standard MRI images. Two readers independently interpreted each CEM and ABMRI after a washout period. Examination-level performance metrics calculated were recall rate, cancer detection, and false-positive biopsy recommendation rates per 1000 examinations and sensitivity, specificity, and positive predictive value of biopsy recommendation. Bootstrap and permutation tests were used to calculate 95% CIs and compare modalities. Results Evaluated were 492 paired CEM and ABMRI interpretations from 246 participants (median age, 51 years; IQR, 43-61 years). On 49 MRI scans with lesions recommended for biopsy, nine lesions showed malignant pathology. No differences in ABMRI and standard MRI performance were identified. Compared with standard MRI, CEM demonstrated significantly lower recall rate (14.0% vs 22.8%; difference, -8.7%; 95% CI: -14.0, -3.5), lower false-positive biopsy recommendation rate per 1000 examinations (65.0 vs 162.6; difference, -97.6; 95% CI: -146.3, -50.8), and higher specificity (87.8% vs 80.2%; difference, 7.6%; 95% CI: 2.3, 13.1). Compared with standard MRI, CEM had significantly lower cancer detection rate (22.4 vs 36.6; difference, -14.2; 95% CI: -28.5, -2.0) and sensitivity (61.1% vs 100%; difference, -38.9%; 95% CI: -66.7, -12.5). The performance differences between CEM and ABMRI were similar to those observed between CEM and standard MRI. Conclusion ABMRI had comparable performance to standard MRI and may support more efficient MRI screening. CEM had lower recall and higher specificity compared with standard MRI or ABMRI, offset by lower cancer detection rate and sensitivity compared with standard MRI. These trade-offs warrant further consideration of patient population characteristics before widespread screening with CEM. Clinical trial registration no. NCT03517813 © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Chang in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Lawson MB, Partridge SC, Hippe DS, et al. Comparative Performance of Contrast-enhanced Mammography, Abbreviated Breast MRI, and Standard Breast MRI for Breast Cancer Screening. Radiology. 2023. PMID: 37581498. doi:10.1148/radiol.230576

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。